Kenna, P. F., Humphries, M. M., Kiang, A., Brabet, P., Guillou, L., Ozaki, E., . . . Humphries, P. (2020). Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. BMJ Open Ophthalmol.

Kenna, Paul F., et al. "Advanced Late-onset Retinitis Pigmentosa With Dominant-acting D477G RPE65 Mutation Is Responsive to Oral Synthetic Retinoid Therapy." BMJ Open Ophthalmol 2020.

Kenna, Paul F., et al. "Advanced Late-onset Retinitis Pigmentosa With Dominant-acting D477G RPE65 Mutation Is Responsive to Oral Synthetic Retinoid Therapy." BMJ Open Ophthalmol 2020.